Fig. 6

Anti-aggrecanolytic effect of compounds 2 and 4b on human OA cartilage explants. Compounds 2 and 4b or DMSO were incubated with cartilage explants from OA patients. (A) Representative anti-AGEG immunoblot. ADAMTS5-digested bovine aggrecan was used as a positive control. Asterisk indicates non-specific bands. (B) Densitometric analysis of immunoreactive bands. Data are plotted as scatter dot plots with average ± S.E.M. (n = 3 donors). ***p < 0.001; ****p < 0.0001 compared to DMSO control by one-way ANOVA. ATS5, ADAMTS5; Cpd, compound.